Roberto Franceschi, Riccardo Pertile, Marco Marigliano, Enza Mozzillo, Claudio Maffeis, Elisa Morotti, Francesca Di Candia, Ludovica Fedi, Dario Iafusco, Angela Zanfardino, Vittoria Cauvin, Giulio Maltoni, Stefano Zucchini, Valentino Cherubini, Valentina Tiberi, Nicola Minuto, Marta Bassi, Ivana Rabbone, Silvia Savastio, Davide Tinti, Gianluca Tornese, Riccardo Schiaffini, Stefano Passanisi, Fortunato Lombardo, Riccardo Bonfanti, Andrea Scaramuzza, Alda Troncone
AIMS: While continuous glucose monitoring (CGM) and associated technologies have positive effects on metabolic control in young people with type 1 diabetes (T1D), less is known about their impact on quality of life (QoL). Here, we quantified CGM satisfaction and QoL in young people with T1D and their parents/caregivers to establish (i) the relationship between QoL and CGM satisfaction and (ii) the impact of the treatment regimen on QoL. METHODS: This was a cross-sectional study of children and adolescents with T1D on different treatment regimens (multiple daily injections, sensor-augmented pumps and automated insulin delivery)...
February 21, 2024: Diabetic Medicine: a Journal of the British Diabetic Association